vs
FLEXIBLE SOLUTIONS INTERNATIONAL INC（FSI）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
FLEXIBLE SOLUTIONS INTERNATIONAL INC的季度营收约是Profound Medical Corp.的1.5倍（$9.1M vs $6.0M），FLEXIBLE SOLUTIONS INTERNATIONAL INC净利率更高（-5.1% vs -136.8%，领先131.7%）
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业，核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等，服务北美及全球农业、水务领域客户。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
FSI vs PROF — 直观对比
营收规模更大
FSI
是对方的1.5倍
$6.0M
净利率更高
FSI
高出131.7%
-136.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $6.0M |
| 净利润 | $-460.9K | $-8.2M |
| 毛利率 | 29.4% | 66.8% |
| 营业利润率 | 11.6% | -123.3% |
| 净利率 | -5.1% | -136.8% |
| 营收同比 | -0.5% | — |
| 净利润同比 | -167.8% | — |
| 每股收益（稀释后） | $-0.03 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSIPROF
| Q4 25 | $9.1M | $6.0M | ||
| Q3 25 | $10.6M | $5.1M | ||
| Q2 25 | $11.4M | $2.0M | ||
| Q1 25 | $7.5M | $2.3M | ||
| Q4 24 | $9.2M | — | ||
| Q3 24 | $9.3M | — | ||
| Q2 24 | $10.5M | — | ||
| Q1 24 | $9.2M | — |
净利润FSIPROF
| Q4 25 | $-460.9K | $-8.2M | ||
| Q3 25 | $-503.4K | $-8.0M | ||
| Q2 25 | $2.0M | $-15.7M | ||
| Q1 25 | $-277.7K | $-10.7M | ||
| Q4 24 | $679.6K | — | ||
| Q3 24 | $611.9K | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $457.2K | — |
毛利率FSIPROF
| Q4 25 | 29.4% | 66.8% | ||
| Q3 25 | 23.9% | 77.7% | ||
| Q2 25 | 47.4% | 81.7% | ||
| Q1 25 | 26.1% | 79.2% | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | 40.9% | — | ||
| Q2 24 | 37.4% | — | ||
| Q1 24 | 30.6% | — |
营业利润率FSIPROF
| Q4 25 | 11.6% | -123.3% | ||
| Q3 25 | 2.9% | -176.2% | ||
| Q2 25 | 29.0% | -696.9% | ||
| Q1 25 | -0.9% | -477.0% | ||
| Q4 24 | 9.4% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 8.3% | — |
净利率FSIPROF
| Q4 25 | -5.1% | -136.8% | ||
| Q3 25 | -4.8% | -157.7% | ||
| Q2 25 | 17.8% | -792.3% | ||
| Q1 25 | -3.7% | -458.1% | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 5.0% | — |
每股收益（稀释后）FSIPROF
| Q4 25 | $-0.03 | $0.27 | ||
| Q3 25 | $-0.04 | $0.26 | ||
| Q2 25 | $0.15 | $0.52 | ||
| Q1 25 | $-0.02 | $0.36 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.10 | — | ||
| Q1 24 | $0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $59.7M |
| 总债务越低越好 | $4.4M | $4.5M |
| 股东权益账面价值 | $38.9M | $66.4M |
| 总资产 | $61.8M | $77.5M |
| 负债/权益比越低杠杆越低 | 0.11× | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资FSIPROF
| Q4 25 | — | $59.7M | ||
| Q3 25 | — | $24.8M | ||
| Q2 25 | $10.0M | $35.2M | ||
| Q1 25 | $11.0M | $46.4M | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $13.0M | — | ||
| Q2 24 | $9.2M | — | ||
| Q1 24 | $8.3M | — |
总债务FSIPROF
| Q4 25 | $4.4M | $4.5M | ||
| Q3 25 | $7.1M | $4.5M | ||
| Q2 25 | $7.5M | $4.5M | ||
| Q1 25 | $8.1M | $4.5M | ||
| Q4 24 | $8.8M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $8.3M | — | ||
| Q1 24 | $8.0M | — |
股东权益FSIPROF
| Q4 25 | $38.9M | $66.4M | ||
| Q3 25 | $39.0M | $32.1M | ||
| Q2 25 | $39.4M | $39.3M | ||
| Q1 25 | $38.4M | $50.8M | ||
| Q4 24 | $38.0M | — | ||
| Q3 24 | $36.9M | — | ||
| Q2 24 | $36.2M | — | ||
| Q1 24 | $36.0M | — |
总资产FSIPROF
| Q4 25 | $61.8M | $77.5M | ||
| Q3 25 | $58.4M | $42.3M | ||
| Q2 25 | $58.2M | $49.7M | ||
| Q1 25 | $61.7M | $60.9M | ||
| Q4 24 | $60.0M | — | ||
| Q3 24 | $57.8M | — | ||
| Q2 24 | $56.3M | — | ||
| Q1 24 | $57.6M | — |
负债/权益比FSIPROF
| Q4 25 | 0.11× | 0.07× | ||
| Q3 25 | 0.18× | 0.14× | ||
| Q2 25 | 0.19× | 0.11× | ||
| Q1 25 | 0.21× | 0.09× | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | — |
| 自由现金流率自由现金流/营收 | -44.3% | — |
| 资本支出强度资本支出/营收 | 11.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-591.7K | — |
8季度趋势，按日历期对齐
经营现金流FSIPROF
| Q4 25 | $-3.0M | $-6.6M | ||
| Q3 25 | $2.0M | $-9.6M | ||
| Q2 25 | $5.3M | $-13.7M | ||
| Q1 25 | $-544.3K | $-8.3M | ||
| Q4 24 | $-2.2M | — | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $5.9M | — | ||
| Q1 24 | $-604.8K | — |
自由现金流FSIPROF
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $39.4K | — | ||
| Q2 25 | $4.3M | — | ||
| Q1 25 | $-898.4K | — | ||
| Q4 24 | $-4.3M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $4.7M | — | ||
| Q1 24 | $-1.1M | — |
自由现金流率FSIPROF
| Q4 25 | -44.3% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | -12.0% | — | ||
| Q4 24 | -47.0% | — | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 44.9% | — | ||
| Q1 24 | -11.7% | — |
资本支出强度FSIPROF
| Q4 25 | 11.7% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 8.6% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 13.0% | — | ||
| Q2 24 | 11.3% | — | ||
| Q1 24 | 5.2% | — |
现金转化率FSIPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.60× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.27× | — | ||
| Q3 24 | 4.05× | — | ||
| Q2 24 | 4.59× | — | ||
| Q1 24 | -1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
